Despite Regulatory Win, Call Writers Gamble on Limited Upside for Affymetrix
Posted on May 09, 2011 at 13:51 PM EDT
Call traders have converged on Affymetrix, Inc. (AFFX - 6.20) today, after the Food & Drug Administration (FDA) approved the use of its new gene expression agents with its genetic analysis tools...( Read More )